Transgenic mice with hematopoietic and lymphoid specific expression of Cre

被引:615
作者
de Boer, J [1 ]
Williams, A [1 ]
Skavdis, G [1 ]
Harker, N [1 ]
Coles, M [1 ]
Tolaini, M [1 ]
Norton, T [1 ]
Williams, K [1 ]
Roderick, K [1 ]
Potocnik, AJ [1 ]
Kioussis, D [1 ]
机构
[1] Natl Inst Med Res, Dept Mol Immunol, London NW7 1AA, England
基金
英国医学研究理事会;
关键词
GFP; Vav-iCre; hCD2-iCre; hematopoiesis; lymphocyte; transgenic;
D O I
10.1002/immu.200310005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Bacteriophage P1 Cre/IoxP based systems can be used to manipulate the genomes of mice in vivo and in vitro, allowing the generation of tissue-specific conditional mutants. We have generated mouse lines expressing Cre recombinase in hematopoietic tissues using the vav regulatory elements, or in lymphoid cells using the hCD2 promoter and locus control region (LCR). The R26R-EYFP Cre reporter mouse line was used to determine the pattern of Cre expression in each line and enabled the assessment of Cre activity at a single-cell level. Analysis showed that the vav promoter elements were able to direct Cre-mediated recombination in all cells of the hematopoietic system. The hCD2 promoter and LCR on the other hand were able to drive Cre-mediated recombination only in T cells and B cells, but not in other hematopoietic cell types. Furthermore, in the appropriate tissues, deletion of the floxed target was complete in all cells, thereby excluding the possibility of variegated expression of the Cre transgene. Both of these Cre-transgenic lines will be useful in generating tissue-specific gene deletions within all the cells of hematopoietic or lymphoid tissues.
引用
收藏
页码:314 / 325
页数:12
相关论文
共 45 条
[1]
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector [J].
Adams, JM ;
Harris, AW ;
Strasser, A ;
Ogilvy, S ;
Cory, S .
ONCOGENE, 1999, 18 (38) :5268-5277
[2]
ADAMS JM, 1992, ONCOGENE, V7, P611
[3]
A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor [J].
Brocard, J ;
Feil, R ;
Chambon, P ;
Metzger, D .
NUCLEIC ACIDS RESEARCH, 1998, 26 (17) :4086-4090
[4]
BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297
[5]
Characterization of transgene expression and Cre recombinase activity in a panel of Thy-1 promoter-Cre transgenic mice [J].
Campsall, KD ;
Mazerolle, CJ ;
De Repentingy, Y ;
Kothary, R ;
Wallace, VA .
DEVELOPMENTAL DYNAMICS, 2002, 224 (02) :135-143
[6]
DEATH BEFORE BIRTH - CLUES FROM GENE KNOCKOUTS AND MUTATIONS [J].
COPP, AJ .
TRENDS IN GENETICS, 1995, 11 (03) :87-93
[7]
Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes [J].
Dietrich, P ;
Dragatsis, I ;
Xuan, SH ;
Zeitlin, S ;
Efstratiadis, A .
MAMMALIAN GENOME, 2000, 11 (03) :196-205
[8]
Locus control region function and heterochromatin-induced position effect variegation [J].
Festenstein, R ;
Tolaini, M ;
Corbella, P ;
Mamalaki, C ;
Parrington, J ;
Fox, M ;
Miliou, A ;
Jones, M ;
Kioussis, D .
SCIENCE, 1996, 271 (5252) :1123-1125
[9]
Variegated expression of a globin transgene correlates with chromatin accessibility but not methylation status [J].
Garrick, D ;
Sutherland, H ;
Robertson, G ;
Whitelaw, E .
NUCLEIC ACIDS RESEARCH, 1996, 24 (24) :4902-4909
[10]
CONTROL POINTS IN EARLY T-CELL DEVELOPMENT [J].
GODFREY, DI ;
ZLOTNIK, A .
IMMUNOLOGY TODAY, 1993, 14 (11) :547-553